Dr. Pramod Kumar Pandey, PhD (Chemistry), is the Founder of PharmaGuru.co and a senior Analytical Research Expert with over 31 years of experience in the pharmaceutical industry. He specializes in analytical method development and validation, pharmaceutical research, quality control, quality assurance, and regulatory compliance, and has contributed to analytical innovation and quality excellence across leading Indian and global pharmaceutical companies.
Contact: admin@pharmaguru.co
Learn Good Documentation Practice (GDP) in pharmaceuticals, including definition, principles, 10 Cs, regulatory requirements, key components, and FAQs.
Good Documentation Practice (GDP) in Pharmaceuticals: Definition, Principles, 10 Cs, Regulatory Requirements, Key Components & FAQs
SOP and STP (Source: Bing)
Introduction and Outcome
Good Documentation Practice (GDP) plays a critical role in the pharmaceutical industry because documentation is the most valuable asset of any regulated organisation. No matter how well a process is designed—from route selection and development to manufacturing and distribution—if an activity is not documented, it is considered not done.
GDP ensures the quality, safety, efficacy, traceability, and compliance of pharmaceutical products. It is also a core pillar of GLP, GMP, and GCP systems. In this article, you will learn:
Good Documentation Practices (GDP) define the best practices for creating, reviewing, approving, maintaining, and archiving paper and electronic documents in regulated environments.
GDP applies to all critical pharmaceutical documents, including:
SOPs and STPs
Analytical method validation and technology transfer documents
Raw data, laboratory notebooks, and batch records
Deviations (OOS, OOT), investigations, and CAPA reports
The principles of GDP focus on ensuring that documentation is:
Accurate and clear
Timely and traceable
Consistent and legible
Authorised and version-controlled
Secure and retained appropriately
Reviewed, validated, and risk-based
Continuously improved through root cause analysis
10 Cs of Good Documentation Practices
The 10 Cs define effective document writing:
Clear – Simple and precise explanations
Concise – No unnecessary words
Correct – Free from grammatical and factual errors
Coherent – Logical and structured flow
Complete – All required information included
Creative – Expert-driven explanations where needed
Considerate – Easy to read with headings and bullets
Concrete – Specific details (dates, numbers, quantities)
Courteous – Professional tone, avoid commands
Credible – Fact-based, not opinion-based
Regulatory Requirements for GDP
GDP compliance is a legal and regulatory requirement in the pharmaceutical industry. Regulatory bodies such as the FDA, EMA, WHO, and ICH mandate strict documentation standards.
GDP is enforced through:
21 CFR Parts 210, 211, 58, and 11
EU GMP Annexes
WHO GMP guidelines
Failure to comply may lead to 483 observations, warning letters, recalls, or regulatory bans.
4 Key Components of Good Documentation Practices
1. Document Hierarchy and Organisation
A structured hierarchy improves accessibility, consistency, and audit readiness.
2. Document Control and Versioning
Ensures only current, approved documents are in use and older versions are archived.
3. Data Integrity and Validation
Maintains data accuracy, completeness, and reliability throughout its lifecycle.
4. Document Review and Approval
Formal QA review and approval ensure regulatory compliance and quality assurance.
5 Best Practices for Document Creation and Management
Define clear objectives and purpose
Standardise templates and formatting
Implement efficient review and approval workflows
Ensure document security and confidentiality
Maintain accuracy and completeness
GDP Across Pharmaceutical Departments
Manufacturing
Batch manufacturing records
Equipment calibration and maintenance logs
Environmental monitoring records
Quality Control (QC) and Quality Assurance (QA)
Test methods, results, and investigations
OOS/OOT documentation
Equipment qualification and validation records
Analytical & Chemical R&D
Experimental protocols and observations
Research findings and conclusions
Intellectual property documentation
Training, Compliance, and GDP
Regular GDP training is mandatory
Training records must be documented
Employees must understand the regulatory impact of documentation
Documenting Changes, Deviations, and Investigations
GDP ensures:
Proper change control documentation
Transparent deviation and incident reporting
Effective communication to stakeholders
Role of GDP in Audits and Inspections
Effective GDP:
Enables quick document retrieval
Reduces audit observations
Supports CAPA implementation and continuous improvement
GDP, Electronic Documentation, and Data Integrity
SOPs must govern electronic documentation
Use validated EDMS, LIMS, and ELNs
Ensure audit trails, access control, and data security
Comply with 21 CFR Part 11
GDP in Record Retention and Archiving
Defined retention timelines
Secure and controlled storage
Easy retrieval for audits and inspections
Controlled destruction after the retention period
Do’s and Don’ts of Good Documentation Practices
Do’s
Write clearly and concisely
Use approved templates
Record data in real time
Maintain version control
Sign, date, and review documents
Don’ts
Do not overwrite or erase data
Do not leave blanks (use “N/A”)
Do not backdate entries
Do not use unapproved templates
Do not skip reviews or approvals
3 Examples of GDP in Quality Control
Accurate Record Keeping – Legible, traceable, and secure QC records
SOP Compliance – Approved and trained procedures
Audit Trails – Full traceability of changes and results
Advantages of Good Documentation Practices
Ensures regulatory compliance
Improves product quality and safety
Builds data integrity and trust
Enables audit readiness
Protects the company’s reputation
Conclusion
Good Documentation Practice (GDP) is the foundation of pharmaceutical quality systems. It ensures compliance, traceability, data integrity, and patient safety. By implementing robust GDP principles, organisations can enhance operational efficiency, pass regulatory inspections, and foster a strong culture of quality and transparency.